Ameriprise’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-42,951
| Closed | -$267K | – | 3965 |
|
|
2022
Q4 | $267K | Buy |
42,951
+12
| +0% | +$75 | ﹤0.01% | 3622 |
|
|
2022
Q3 | $287K | Sell |
42,939
-1,970
| -4% | -$13.2K | ﹤0.01% | 3593 |
|
|
2022
Q2 | $286K | Buy |
44,909
+26,510
| +144% | +$169K | ﹤0.01% | 3572 |
|
|
2022
Q1 | $86K | Sell |
18,399
-94,245
| -84% | -$441K | ﹤0.01% | 3852 |
|
|
2021
Q4 | $564K | Buy |
+112,644
| New | +$564K | ﹤0.01% | 3474 |
|
|
2020
Q2 | – | Sell |
-5,983
| Closed | -$327K | – | 3693 |
|
|
2020
Q1 | $327K | Buy |
+5,983
| New | +$327K | ﹤0.01% | 3279 |
|
|
2019
Q3 | – | Sell |
-25,640
| Closed | -$1.19M | – | 3708 |
|
|
2019
Q2 | $1.19M | Buy |
25,640
+145
| +0.6% | +$6.75K | ﹤0.01% | 2985 |
|
|
2019
Q1 | $1.02M | Sell |
25,495
-70
| -0.3% | -$2.81K | ﹤0.01% | 3028 |
|
|
2018
Q4 | $1.18M | Buy |
25,565
+16,400
| +179% | +$754K | ﹤0.01% | 2878 |
|
|
2018
Q3 | $406K | Buy |
+9,165
| New | +$406K | ﹤0.01% | 3352 |
|
|
2018
Q2 | – | Sell |
-21,472
| Closed | -$1.55M | – | 3643 |
|
|
2018
Q1 | $1.55M | Sell |
21,472
-3,762
| -15% | -$272K | ﹤0.01% | 2782 |
|
|
2017
Q4 | $1.66M | Buy |
25,234
+321
| +1% | +$21.1K | ﹤0.01% | 2748 |
|
|
2017
Q3 | $1.25M | Sell |
24,913
-9,368
| -27% | -$469K | ﹤0.01% | 2865 |
|
|
2017
Q2 | $1.59M | Sell |
34,281
-8,110
| -19% | -$375K | ﹤0.01% | 2722 |
|
|
2017
Q1 | $1.5M | Buy |
+42,391
| New | +$1.5M | ﹤0.01% | 2707 |
|
|
2015
Q2 | – | Sell |
-17,587
| Closed | -$1.63M | – | 3987 |
|
|
2015
Q1 | $1.63M | Sell |
17,587
-22,061
| -56% | -$2.04M | ﹤0.01% | 2683 |
|
|
2014
Q4 | $1.6M | Buy |
+39,648
| New | +$1.6M | ﹤0.01% | 2650 |
|